Examples of 'open-label' in a sentence
Meaning of "open-label"
Open-label: denoting a clinical trial in which both the researchers and the participants know which treatment is being administered
How to use "open-label" in a sentence
Basic
Advanced
open-label
In the open-label study there was no difference in.
This was followed by an open-label extension phase.
An open-label trial may still be randomized.
The study was an open-label single dose study.
An open-label extension study will follow.
Therefore the studies were performed as open-label studies.
The study was open-label with no placebo group.
Is controlled studies and one was an open-label study.
An open-label study is when no standard treatment or placebo is utilized.
Treatment was administered in an open-label fashion.
In an open-label trial the identity of treatment is known to all.
Drugs are packaged in an open-label fashion.
An open-label crossover study was conducted in eight peritoneal dialysis patients.
Or controlled studies and one was an open-label study.
The study was conducted in open-label setting, with no blinding of interventions.
See also
Most studies have been conducted on an open-label basis.
In an open-label trial zonisamide attenuated the symptoms of tardive dyskinesia.
The majority of these studies were open-label controlled studies.
Part two was an open-label study of pexidartinib for all patients.
A blind trial is the opposite of an open or open-label trial.
In the open-label trial, no objective improvement or worsening of clinical symptoms was observed.
The study was initiated with up to two open-label treatment cycles.
As in any open-label study, unblinded assessments can result in exaggerated results.
Seventeen subjects completed the open-label dose evaluation period.
It was an open-label trial, and women and healthcare professionals were not blinded.
Safety data in paediatric patients have been obtained from one open-label.
In the open-label study there was no difference in overall survival between patients treated a.
These responses persisted through 3 years of therapy in an open-label extension study.
The data are from an open-label study and no firm conclusions can be drawn.
The potential drug showed clinical benefit in a small open-label trial.
In an open-label extension study, one patient developed bacterial meningitis and died.
If a recurrence occurred while on study drug treatment, patients were switched to open-label caplacizumab.
Findings in an open-label follow up to this study suggest possible benefit in some individuals.
Patients completing the trial will be offered participation in an open-label extension trial.
In this open-label trial all participants will receive the experimental drug.
One patient withdrew from the trial during the open-label extension.
Open-label case series have suggested that primidone is effective in the treatment of epilepsy.
We judged the potential for risk of bias in this open-label study as moderate.
Despite this, open-label trials were undergone in humans which showed only modest benefits.
We also performed a pre-specified sensitivity analysis excluding any open-label studies.
In the open-label extension, improvement in the signs and symptoms was maintained with adalimumab.
As far as what evidence we do have with trazodone, there is one open-label study.
This open-label study includes a first phase of dose escalation, followed by an extension phase.
There was also an option for patients to be enrolled in an open-label year-three extension.
Open-label therapy with amlodipine was not permitted throughout the course of the trial.
Subsequently, the company has made the decision to discontinue the open-label extension.
Six other randomized open-label medical-treatment controlled trials without placebo control were published.
Injection method and duration could not be effectively blinded, so the study was open-label.
The open-label phase of the study confirmed the safety of the buprenorphine-naloxone combination.
Improvement in health-related quality of life and physical function was maintained during the open-label.
